Spending on Dual Over-the-Counter and Prescription Drugs in the Medicare Part D Program
JAMA · 2024
DOI: 10.1001/jama.2023.23126 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, 2024. Verfasst von Mariana P Socal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. Hauptthemen laut MEDLINE: Medicare Part D, Prescription Drugs, Nonprescription Drugs. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This study compares Medicare and patient spending for dual over-the-counter and prescription drugs with their over-the-counter cash prices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
- Neeley School of Business, Texas Christian University, Fort Worth.
- Johns Hopkins Carey Business School, Washington, DC.
Zitieren
APA
Socal, M. P., Wang, Y., Plummer, E., Anderson, G. F., & Bai, G. (2024). Spending on Dual Over-the-Counter and Prescription Drugs in the Medicare Part D Program. JAMA. https://doi.org/10.1001/jama.2023.23126
Vancouver
Socal MP, Wang Y, Plummer E, Anderson GF, Bai G. Spending on Dual Over-the-Counter and Prescription Drugs in the Medicare Part D Program. JAMA. 2024. doi:10.1001/jama.2023.23126
BibTeX
@article{Socal2024,
author = {Socal, Mariana P and Wang, Yuchen and Plummer, Elizabeth and Anderson, Gerard F and Bai, Ge},
title = {Spending on Dual Over-the-Counter and Prescription Drugs in the Medicare Part D Program},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2023.23126}
}
EUVIMED